|  Help  |  About  |  Contact Us

Publication : Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.

First Author  Datta SK Year  2010
Journal  Proc Natl Acad Sci U S A Volume  107
Issue  23 Pages  10638-43
PubMed ID  20479237 Mgi Jnum  J:165056
Mgi Id  MGI:4836125 Doi  10.1073/pnas.1002348107
Citation  Datta SK, et al. (2010) Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A 107(23):10638-43
abstractText  Cholera toxin (CT) elicits a mucosal immune response in mice when used as a vaccine adjuvant. The mechanisms by which CT exerts its adjuvant effects are incompletely understood. We show that protection against inhalation anthrax by an irradiated spore vaccine depends on CT-mediated induction of IL-17-producing CD4 Th17 cells. Furthermore, IL-17 is involved in the induction of serum and mucosal antibody responses by CT. Th17 cells induced by CT have a unique cytokine profile compared with those induced by IL-6 and TGF-beta, and their induction by CT requires cAMP-dependent secretion of IL-1beta and beta-calcitonin gene-related peptide by dendritic cells. These findings demonstrate that Th17 cells mediate mucosal adjuvant effects of CT and identify previously unexplored pathways involved in Th17 induction that could be targeted for development of unique mucosal adjuvants.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

16 Bio Entities

Trail: Publication

0 Expression